153 related articles for article (PubMed ID: 2893653)
1. Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanisms.
Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
Brain Res; 1987 Dec; 436(2):374-9. PubMed ID: 2893653
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanisms.
Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
NIDA Res Monogr; 1986; 75():524-6. PubMed ID: 2893280
[TBL] [Abstract][Full Text] [Related]
3. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
Long JB; Petras JM; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
[TBL] [Abstract][Full Text] [Related]
4. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
Long JB; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
Rochford J; Godin C; Henry JL
Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
[TBL] [Abstract][Full Text] [Related]
6. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.
Faden AI
Ann Neurol; 1990 Jan; 27(1):67-74. PubMed ID: 1967925
[TBL] [Abstract][Full Text] [Related]
7. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
Knox RJ; Dickenson AH
Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opioids in spinal cord injury: a critical evaluation.
Long JB; Martinez-Arizala A; Petras JM; Holaday JW
Cent Nerv Syst Trauma; 1986; 3(4):295-315. PubMed ID: 2884046
[TBL] [Abstract][Full Text] [Related]
9. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord.
Ren MF; Lu CH; Han JS
Peptides; 1985; 6(6):1015-20. PubMed ID: 2871545
[TBL] [Abstract][Full Text] [Related]
10. Arginine8-vasopressin reduces spinal cord blood flow after spinal subarachnoid injection in rats.
Long JB; Martinez-Arizala A; Johnson SH; Holaday JW
J Pharmacol Exp Ther; 1989 May; 249(2):499-506. PubMed ID: 2524587
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats.
Xue JC; Yu YX; Han JS; Jen MF
Int J Neurosci; 1995 May; 82(1-2):83-93. PubMed ID: 7591518
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats.
Stevens CW; Weinger MB; Yaksh TL
Eur J Pharmacol; 1987 Jun; 138(2):299-302. PubMed ID: 2887441
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal dynorphin A administration causes pressor responses in rats associated with an increased resistance to spinal cord blood flow.
Thornhill JA; Gregor L; Mathison R; Pittman Q
Brain Res; 1989 Jun; 490(1):174-7. PubMed ID: 2569352
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dynorphin A-induced antinociception at spinal level.
Spampinato S; Candeletti S
Eur J Pharmacol; 1985 Mar; 110(1):21-30. PubMed ID: 2861098
[TBL] [Abstract][Full Text] [Related]
15. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
Rady JJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin and dynorphin A(1-17) produce antianalgesia through independent systems in mice.
Rady JJ; Fujimoto JM
Life Sci; 2002 Jan; 70(9):1085-93. PubMed ID: 11860156
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism.
Bakshi R; Newman AH; Faden AI
J Neurosci; 1990 Dec; 10(12):3793-800. PubMed ID: 1980130
[TBL] [Abstract][Full Text] [Related]
18. Intrastriatal injections of dynorphin A fragments potentiate the dorsal immobility response in rats.
Meyer ME
Pharmacol Biochem Behav; 1993 Feb; 44(2):329-32. PubMed ID: 8095341
[TBL] [Abstract][Full Text] [Related]
19. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
Faden AI; Jacobs TP
Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase.
Svensson CI; Hua XY; Powell HC; Lai J; Porreca F; Yaksh TL
Neuropeptides; 2005 Oct; 39(5):485-94. PubMed ID: 16176831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
